Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Ovid Therapeutics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 67 | 62 | −5 |
| Shares | 34.0M | 35.1M | +1.12M (+3.3%) |
| Value | $109.2M | $110.3M | +$1.13M (+1.0%) |
New holders (7)
Institutions that held Ovid Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Driehaus Capital Management LLC | 359,976 | $1.13M | 0.01% |
| Jane Street Group, LLC | 63,508 | $199.0K | 0.00% |
| Man Group plc | 47,863 | $150.0K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 42,028 | $132.0K | 0.00% |
| Mirabella Financial Services LLP | 19,500 | $61.0K | 0.01% |
| Stokes Family Office, LLC | 15,246 | $48.0K | 0.01% |
| Royce & Associates LP | 11,811 | $37.0K | 0.00% |
Sold out (12)
Institutions that held Ovid Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Platinum Investment Management Ltd | 766,901 | $2.46M |
| Anson Funds Management LP | 54,823 | $176.0K |
| Bailard, Inc. | 47,948 | $154.0K |
| Diversified Trust Co | 32,964 | $106.0K |
| Jump Financial, LLC | 16,600 | $53.0K |
| Great Lakes Advisors, LLC | 15,196 | $49.0K |
| Qube Research & Technologies Ltd | 13,989 | $45.0K |
| Winton Group Ltd | 11,829 | $38.0K |
| Cubist Systematic Strategies, LLC | 10,604 | $34.0K |
| Federated Hermes, Inc. | 1,887 | $6.00K |
| High Net Worth Advisory Group LLC | 1,800 | $6.00K |
| CoreCap Advisors, LLC | 4 | – |